Discredited vaccine-autism doc sues critics | MassDevice.com On Call

MassDevice On Call

MASSDEVICE ON CALL — Dr. Andrew Wakefield, whose infamous 1998 research paper in The Lancet found a link between childhood vaccinations and autism, filed a defamation suit against the British Medical Journal and an investigative journalist over a series of articles published last year.

The articles by Brian Deer disclosed discrepancies between a Lancet study and the children’s medical histories. Deer also unearthed financial ties between Wakefield and lawyers fighting against vaccine firms.

Commentaries by BMJ editor Fiona Godlee went so far as to charge Wakefield with deliberately "alter[ing] numerous facts about the patients’ medical histories in order to support his claim to have identified a new syndrome," according to Medpagetoday.com.

Sign up to get our free newsletters delivered straight to your inbox

After The Lancet formally retracted the paper in February 2010, U.K. authorities stripped Wakefield of his license to practice medicine there, finding that he had been "intentionally dishonest and misleading."

Wakefield filed the lawsuit against Deer and BMJ in his adopted town of Austin, Texas, calling the articles "unfair, incorrect, inaccurate, and unjust."

The infamous doctor denied seeing some of the records cited by Deer in his articles before releasing his 1998 paper, saying it would thus have been impossible for him to deliberately mis-state their contents.

Wakefield has sued the publication in British courts in the past, according to the website. Wakefield was responsible for dropping each of the previous cases.

Deer and BMJ told Medpagetoday that they intend to fight the Texas suit. Wakesfield has also been barred from practicing medicine in the U.S.

Health care adds 315,000 jobs in 2011
The health care industry added 23,000 new jobs in December and 315,000 jobs over the course of 2011, according to TheHill.com. Health care employment is one of the fastest-growing sections of the economy. Read more

Romneycare’s annual costs jump $150M in Mass.
The Commonwealth stands to pay $150 million more a year for Mitt Romney’s health care law, after the Bay State’s Supreme Court found that legal immigrants residing in the state must be covered under the equal protection provisions of the Mass. constitution. Read more

Health care reform naysayers add 2 to court cases

A group fighting against President Barack Obama’s health care reform asked the U.S. Supreme Court to add 2 new plaintiffs, after problems arose with the initial plaintiff. Read more

Arizona man gets TAVR valve, an Arizona first
William Ruser, an 84-year-old Arizona man, underwent a successful transcatheter aortic valve replacement surgery at the Scottsdale Healthcare Osborn Medical Center last week. Read more

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply